Analysys Of The Clinical Feature Of COPD Patients With Triple Therapy(ics/laba/lama)

被引：0
|
作者：
Miyazaki, M. [1 ]
Nakamura, H. [2 ]
Sasaki, M. [1 ]
Haraguchi, M. [1 ]
Chubachi, S. [1 ]
Takahashi, S. [1 ]
Yoshida, S. [3 ]
Shirahata, T. [4 ]
Asano, K. [5 ]
Betsuyaku, T. [1 ]
机构：
[1] Keio Univ, Tokyo, Japan
[2] Saitama Med Univ Hosp, Saitama, Japan
[3] Tokyo Med Ctr, Tokyo, Japan
[4] Saitama Social Insurance Hosp, Saitama, Japan
[5] Tokai Univ, Sch Med, Hiratsuka, Kanagawa, Japan
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2013年 / 187卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A4371
引用
收藏
页数：1
相关论文
共 50 条
  • [21] EVELUT®: A Real-World, Observational Study Assessing Dyspnoea and Symptom Burden in COPD Patients Switched from LABA/ICS to LAMA/LABA or LAMA/LABA/ICS
    Roland Buhl
    Michael Dreher
    Muriel Mattiucci-Guehlke
    Rachel Emerson-Stadler
    Sebastian Eckhardt
    Christian Taube
    Claus F. Vogelmeier
    Advances in Therapy, 2023, 40 : 3263 - 3278
  • [22] EVELUT®: A Real-World, Observational Study Assessing Dyspnoea and Symptom Burden in COPD Patients Switched from LABA/ICS to LAMA/LABA or LAMA/LABA/ICS
    Buhl, Roland
    Dreher, Michael
    Mattiucci-Guehlke, Muriel
    Emerson-Stadler, Rachel
    Eckhardt, Sebastian
    Taube, Christian
    Vogelmeier, Claus F.
    ADVANCES IN THERAPY, 2023, 40 (07) : 3263 - 3278
  • [23] LATE-BREAKING ABSTRACT: Single inhaler triple therapy (ICS/LAMA/LABA) in patients with advanced COPD: Results of the FULFIL trial
    Lomas, David
    Lipson, David
    Barnacle, Helen
    Birk, Ruby
    Brealey, Noushin
    Zhu, Chang-Qing
    Tabberer, Maggie
    EUROPEAN RESPIRATORY JOURNAL, 2016, 48
  • [24] Clinical synergism of LABA/LAMA combinations in COPD patients
    Rogliani, Paola
    Calzetta, Luigino
    Ora, Josuel
    Puxeddu, Ermanno
    Cazzola, Mario
    Matera, Maria Gabriella
    EUROPEAN RESPIRATORY JOURNAL, 2017, 50
  • [25] TRIPLE THERAPY (ICS/LABA/LAMA) IN PATIENTS WITH UNCONTROLLED ASTHMA: A SYSTEMATIC REVIEW AND META-ANALYSIS
    Saleh, C.
    Kim, L.
    Whalen-Browne, A.
    Chu, D.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2020, 125 (05) : S37 - S38
  • [26] Impact of ICS/LABA and LABA/LAMA FDCs on functional and clinical outcomes in COPD: A network meta-analysis
    Calzetta, Luigino
    Di Marco, Fabiano
    Blasi, Francesco
    Cazzola, Mario
    Centanni, Stefano
    Micheletto, Claudio
    Rossi, Andrea
    Rogliani, Paola
    PULMONARY PHARMACOLOGY & THERAPEUTICS, 2019, 59
  • [27] Ellithe: A prospective non-interventional Study to Assess the Quality of Life and Symptoms in COPD Patients receiving LAMA/LABA/ICS Triple Therapy
    Beeh, M. K.
    Scheithe, K.
    Brinkmann, R.
    PNEUMOLOGIE, 2022, 76 : S4 - S4
  • [28] Effectiveness of Treatment With Dual Bronchodilation (LABA/LAMA) Compared With Combination Therapy (LABA/ICS) for Patients With COPD: A Population-Based Study
    Monteagudo, Monica
    Nunez, Alexa
    Barrecheguren, Miriam
    Miravitlles, Marc
    ARCHIVOS DE BRONCONEUMOLOGIA, 2022, 58 (10): : 699 - 707
  • [29] LABA/LAMA combinations versus LAMA monotherapy or LABA/ICS in COPD: a systematic review and meta-analysis
    Rodrigo, Gustavo J.
    Price, David
    Anzueto, Antonio
    Singh, Dave
    Altman, Pablo
    Bader, Giovanni
    Patalano, Francesco
    Fogel, Robert
    Kostikas, Konstantinos
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2017, 12 : 907 - 922
  • [30] LAMA/LABA vs ICS/LABA in the treatment of COPD in Japan based on the disease phenotypes
    Hizawa, Nobuyuki
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2015, 10 : 1093 - 1102
12345